Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

Q: What does CUSIP 98943L107 represent in this 13F holders report?

CUSIP 98943L107 is the security identifier for ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in Q1 2021?

93 institutional investors reported ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 98943L107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock,$0.001 par value per share
Shares outstanding: 72,096,078
Total 13F shares: 36,327,192
Share change: -972,167
Total reported value: $1,576,156,109
Price per share: $43.39
Number of holders: 93
Value change: -$55,960,381
Number of buys: 49
Number of sells: 49

Quarterly Holders Quick Answers

What is CUSIP 98943L107?
CUSIP 98943L107 identifies ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 98943L107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	8.4%	6,092,078	$316,422,000	—	31 Dec 2020	13F
Matrix Capital Management Company, LP	13F	Company	5.3%	3,821,739	$198,501,000	—	31 Dec 2020	13F
VIKING GLOBAL INVESTORS LP	13F	Company	4.2%	3,011,284	$156,406,000	—	31 Dec 2020	13F
TYBOURNE CAPITAL MANAGEMENT (HK) LTD	13F	Company	3.7%	2,664,409	$138,389,000	—	31 Dec 2020	13F
Redmile Group, LLC	13F	Company	3.4%	2,416,406	$125,508,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	3.3%	2,346,137	$121,857,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	3.2%	2,275,149	$118,172,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	2.1%	1,503,870	$78,112,000	—	31 Dec 2020	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.9%	1,371,690	$71,246,000	—	31 Dec 2020	13F
Avidity Partners Management LP	13F	Company	1.6%	1,135,000	$58,952,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.5%	1,094,026	$56,824,000	—	31 Dec 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.5%	1,050,003	$54,537,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	1.2%	891,509	$46,305,000	—	31 Dec 2020	13F
Capital World Investors	13F	Company	1.2%	850,000	$44,149,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.2%	834,448	$43,341,000	—	31 Dec 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.2%	832,000	$43,214,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	1.1%	779,075	$40,465,000	—	31 Dec 2020	13F
Mayo Clinic	13F	Company	0.5%	362,459	$18,826,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.46%	331,789	$17,233,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.45%	327,197	$16,995,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.39%	282,442	$14,670,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.38%	276,069	$14,339,000	—	31 Dec 2020	13F
Polar Capital Holdings Plc	13F	Company	0.31%	225,000	$11,687,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.31%	223,983	$11,633,000	—	31 Dec 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.26%	190,796	$9,910,000	—	31 Dec 2020	13F
AXA S.A.	13F	Company	0.22%	160,970	$8,361,000	—	31 Dec 2020	13F
Woodline Partners LP	13F	Company	0.19%	140,000	$7,272,000	—	31 Dec 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.18%	132,642	$6,889,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.17%	124,488	$6,466,000	—	31 Dec 2020	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.16%	118,424	$6,151,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.15%	105,992	$5,505,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.14%	100,920	$5,242,000	—	31 Dec 2020	13F
GREAT LAKES ADVISORS, LLC	13F	Company	0.14%	100,335	$5,211,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.13%	96,621	$5,018,000	—	31 Dec 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	63,652	$3,306,000	—	31 Dec 2020	13F
Marshall Wace North America L.P.	13F	Company	0.08%	59,629	$3,097,000	—	31 Dec 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.08%	57,031	$2,962,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	48,064	$2,496,000	—	31 Dec 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.06%	45,287	$2,352,000	—	31 Dec 2020	13F
Pentwater Capital Management LP	13F	Company	0.06%	45,000	$2,337,000	—	31 Dec 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.06%	43,480	$2,258,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.06%	40,700	$2,114,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	40,000	$2,078,000	—	31 Dec 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	32,457	$1,686,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.04%	31,374	$1,629,000	—	31 Dec 2020	13F
Allianz Asset Management GmbH	13F	Company	0.04%	26,955	$1,400,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	25,100	$1,304,000	—	31 Dec 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.03%	24,493	$1,272,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	23,377	$1,214,000	—	31 Dec 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.03%	23,336	$1,212,000	—	31 Dec 2020	13F

Institutional Holders of Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) as of Q1 2021

As of 31 Mar 2021, Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,327,192 shares. The largest 10 holders included FMR LLC, Matrix Capital Management Company, LP, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, VANGUARD GROUP INC, VIKING GLOBAL INVESTORS LP, BlackRock Inc., Redmile Group, LLC, STATE STREET CORP, FEDERATED HERMES, INC., and PRIMECAP MANAGEMENT CO/CA/. This page lists 93 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

104

Q1 2021 holders

Holder diff

-11

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.